Literature DB >> 19339185

Bilateral internal ophthalmoplegia as an initial sole manifestation of Miller Fisher syndrome.

Jong Seok Bae1, Jong Kuk Kim, Sung Hoon Kim, Oeung Kyu Kim.   

Abstract

Although there have been reports regarding the frequent involvement of the pupils in Miller Fisher syndrome (MFS) and related syndromes, internal ophthalmoplegia has not been described as the initial sole manifestation of typical MFS. Recently, we encountered a woman with MFS whose initial manifestation was blurred vision because of bilateral tonic pupils. Investigations, including brain imaging, cerebrospinal fluid examination and nerve conduction studies were normal except for elevated serum levels of immunoglobulin G anti-GQ1b antibody. During the disease, she subsequently developed bilateral sixth and seventh nerve palsies, gait ataxia, and areflexia. We treated her with intravenous immunoglobulin and she showed a stepwise recovery from her illness. This case suggests that bilateral internal ophthalmoplegia can be a preceding sole manifestation of typical MFS.

Entities:  

Mesh:

Year:  2009        PMID: 19339185     DOI: 10.1016/j.jocn.2008.09.009

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  4 in total

1.  An unusual case of Parinaud's syndrome.

Authors:  Maria Mallia; Charmaine Chircop; Josanne Aquilina
Journal:  BMJ Case Rep       Date:  2012-11-21

2.  Pupillary Involvement in Miller Fisher Syndrome.

Authors:  Bahar Kaymakamzade; Ferda Selcuk; Aydan Koysuren; Ayse Ilksen Colpak; Senem Ertugrul Mut; Tulay Kansu
Journal:  Neuroophthalmology       Date:  2013-05-31

3.  Atypical Miller Fisher Syndrome with Anisocoria and Rapidly Fluctuating Pupillary Diameter.

Authors:  Garima Gupta; Antonio Liu
Journal:  Case Rep Neurol Med       Date:  2015-08-24

4.  Miller-Fisher Syndrome: Is the ataxia central or peripheral?

Authors:  Robert D Sandler; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2015-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.